Scleroderma Disease

DESCRIPTION
Scleroderma (systemic sclerosis [SSc]) is a chronic disease of unknown etiology, characterized by diffuse fibrosis, degenerative changes, and vascular abnormalities in the skin, articular structures and other organs (kidneys, lung, heart, gastrointestinal and skeletal muscles). The majority of manifestations have vascular features (e.g., Raynaud's phenomenon), but frank vasculitis is rarely seen. It can range from a mild disease, affecting the skin, to a systemic disease that can cause death in a few months.
  • Divided into two major clinical variants:
    • Diffuse - distal and maximal extremity and truncal skin thickening
    • Limited - restricted to the fingers, hands and face. CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmobility, sclerodactyly, telangiectasia) closely analogous with limited scleroderma.
  • System(s) affected: Skin/Exocrine, Renal/Urologic, Cardiovascular, Gastrointestinal, Musculoskeletal, Pulmonary
  • Genetics: Familial clustering is rare, but has been seen
  • Incidence/Prevalence in USA: 1/100,000
  • Predominant age:
    • Young adult (16–40 years); middle age (40–75 years)
    • Symptoms usually appear in the 3rd to 5th decade
  • Predominant sex: Female > Male (4:1)
SIGNS AND SYMPTOMS
  • Skin
    • Digital ulcerations
    • Tightness, swelling, thickening of digits
    • Hyperpigmentation, hypopigmentation
    • Narrowed oral aperture
    • Pruritus
    • Scaling of skin
    • Subcutaneous calcinosis
  • Peripheral vascular system
    • Raynaud's phenomenon
    • Telangiectasia
  • Joints, tendons and bones
    • Flexion contractures
    • Friction rub on tendon movement
    • Hand swelling
    • Joint stiffness
    • Polyarthralgia
    • Sclerodactyly
  • Muscle
    • Proximal muscle weakness
    • Weakness
  • Gastrointestinal tract
    • Dysphagia
    • Esophageal reflux
    • Malabsorptive diarrhea
    • Nausea and vomiting
    • Weight loss
    • Xerostomia
  • Kidney
    • Hypertension
  • Pulmonary
    • Dry crackles at lung bases
    • Dyspnea
  • Nervous system
    • Peripheral neuropathy
    • Trigeminal neuropathy
CAUSES
  • Unknown
  • Possible alterations in immune response
  • Possibly some association with quartz mining, quarrying, vinyl chloride, hydrocarbons, toxin exposure, rape seed oil
  • Treatment with bleomycin has caused a scleroderma-like syndrome
RISK FACTORS

Unknown

LABORATORY
  • Increased ESR
  • Normocytic anemia
  • Normochromic anemia
  • Positive ANA, often with a nucleolar pattern
  • Anti-centromere antibody
  • Anti-Scl-70 (topoisomerase antibody)
  • Albuminuria
  • Microscopic hematuria
  • Eosinophilia
  • Hemolysis
  • Hypergammaglobulinemia
  • Decreased maximum breathing capacity
  • Increased residual volume
  • Diffusion defect
  • Positive rheumatoid factor test (33%)

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • Skin: edema, fibrosis or atrophy (late stage)
  • Lymphocytic infiltrate around sweat glands
  • Loss of capillaries
  • Endothelial proliferation
  • Hair follicle atrophy
  • Synovium - pannus formation, fibrin deposits in tendons
  • Kidney - small kidneys, intimal proliferation in interlobular arteries
  • Heart - endocardial thickening, myocardial interstitial fibrosis, ischemic band necrosis
  • Enlarged heart
  • Cardiac hypertrophy
  • Lung - interstitial pneumonitis, cyst formation
  • Interstitial fibrosis
  • Bronchiectasis
  • Esophagus - esophageal atrophy, fibrosis
SPECIAL TESTS
  • Skin biopsy - compact collagen fibers in the reticular dermis with hyalinization and fibrosis of arterioles; thinning of epidermis with loss of rete pegs and atrophy of dermal appendages; accumulation of mononuclear cells.
  • ECG - low voltage; possibly nonspecific abnormalities
  • Lung function tests - decreased diffusion and vital capacity
  • Nail fold capillary loop abnormalities
IMAGING
  • Hand X-ray - acro-osteolysis, soft tissue atrophy, subcutaneous calcinosis
  • Upper GI - distal esophageal dilatation, atonic esophagus, esophageal dysmobility, duodenal diverticula
  • Barium enema - colonic diverticula, megacolon
  • Chest X-ray - diffuse reticular pattern, bilateral basilar pulmonary fibrosis
  • Gallium-67 lung scan - can be positive in early interstitial disease
  • High-resolution CT scan for detecting alveolitis - “ground glass” appearance or “honeycomb” pattern in fibrosis
DIAGNOSTIC PROCEDURES

N/A

APPROPRIATE HEALTH CARE

Outpatient. Inpatient possibly for some surgical procedures.

GENERAL MEASURES
  • Treatment is symptomatic and supportive
  • Esophageal dilatation for strictures
  • Avoid cold, dress appropriately for the weather
  • Avoid smoking (crucial)
  • For chronic digital ulcerations – débridement after soaking in half-strength hydrogen peroxide solution; digital plaster to immobilize
  • Physical therapy to maintain function and promote strength
  • Avoid finger sticks (e.g., blood tests)
  • Be wary of air conditioning
  • Heat therapy to relieve joint stiffness
  • Elevation of the head of the bed during sleep may help relieve gastrointestinal symptoms
  • Skin – use softening lotions, ointments, bath oils to help prevent dryness and cracking
  • Dialysis may be necessary in renal crisis
SURGICAL MEASURES

Some success with gastroplasty for correction of gastroesophageal reflux

ACTIVITY

Stay as active as possible, but avoid fatigue

DIET
  • Soft, bland diet with frequent small meals
  • Drink plenty of fluids with meals
PATIENT EDUCATION
  • Printed patient information available from: Scleroderma Federation, 1725 York Avenue, No. 29F, New York, NY 10128, (212) 427-7040
  • Advise patient to report any abnormal bruising or non-healing abrasions
  • Assist patient in smoking cessation, if needed
PREVENTION/AVOIDANCE

None

POSSIBLE COMPLICATIONS
  • Renal failure
  • Respiratory failure
  • Flexion contractures
  • Disability
  • Esophageal dysmotility
  • Reflux esophagitis
  • Arrhythmia
  • Megacolon
  • Pneumatosis intestinalis
  • Obstructive bowel
  • Cardiomyopathy
  • Death
EXPECTED COURSE AND PROGNOSIS
  • Variable
  • Possible improvement, but incurable
  • Prognosis is poor if cardiac, pulmonary, or renal manifestations present early
ASSOCIATED CONDITIONS
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Polymyositis
  • Overlap connective tissue disease
AGE-RELATED FACTORS

Pediatric: Rare in this age group
Geriatric: Not rare until after age 75
Others: N/A

PREGNANCY

N/A

OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.